PATENT CLAIM ANALYSIS

Application Number: 16178198
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "400000"]

Abstract:
In one aspect, the present invention relates to a new method of treating or osteoarthritis in a mammal in need thereof. In certain embodiments, the method comprises contacting at least one biomimetic proteoglycan with the affected joint of the mammal. The biomimetic proteoglycan comprises a core structure and at least one bristle. The biomimetic proteoglycan resists endogenous enzymatic degradation and integrates with the existing tissue matrix.

Claim (Index 16):
The method of  claim 1 , wherein the biomimetic proteoglycan is crosslinked to itself and/or an additional molecule.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.6
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14004944', '10896546', '13173658', '14119341', '14914452']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.739481971080179
- 35 USC 102 Novelty (BERT): 0.5252082250282599
- Combined Prediction Score: 0.718054596474987
- Mean Citation Score: 279.74082000000004
- Max Citation Score: 312.3952
- Similarity Product: 183.0725514135361

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test